Venous Blood: Collect 4mL, store at 2-8°C. Transport with biological ice packs (2-8°C) within 72 hours. Use an EDTA anticoagulant tube.
Reporting Cycle
10 working days
Clinical Application Overview
1. Chromosomal Abnormalities Screening: Screen for chromosomal abnormalities in children with developmental issues, intellectual disabilities, multiple malformations, and other illnesses. Provide guidance for disease confirmation and treatment.
2. Genetic Causes Identification: Identify genetic causes of recurrent miscarriage and infertility. Offer follow-up fertility guidance and recommendations.
Breaking Barriers: Innovations in Gynecologic Cancer TreatmentJune 26, 2023Gynecologic cancers, which include ovarian, uterine, cervical, vaginal, and vulvar cancers, affect thousands of women worldwide. The diagnosis of gynecologic cancer can be devastating, but thanks to o...view
What Are the Diagnostic Methods for Breast Cancer?April 4, 2023Breast cancer has become a terrifying disease that kills female friends with increasing clinical incidence rate. It not only harms women's health but also has a great impact on our normal life. So...view
Chromosome Microarray (CMA) Detection (3)August 27, 2024Testing ContentDetection of 23 pairs of chromosomal aneuploidy and whole genome chromosomal abnormalities greater than 100kb.Testing MethodMicroarray Chip MethodCMA ChipSample RequirementsVenous Blood...view
CapitalBio: A Complete Microarray Platform from Sample to ResultsMay 22, 2024CapitalBio, as a company with profound accumulation in the field of biotechnology, has always been committed to providing high-quality and high-efficiency research tools and services to the majority o...view